ARCHIVES

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

This article is from The Cancer Letter archive.

Vol. 34 No. 13 | April 4, 2008

Download PDF Visit The Full Archive

Related Articles

“Sloppy Work” May Invalidate Methylene Chloride Study; Contractor Hints NTP Pressured By Industry

October 14, 1983

AHCPR Invites Ideas for Outcomes Research

June 7, 1996

NSABP’s B-14 Study Reports Deaths From Uterine Cancer Related To Tamoxifen

February 25, 1994

NCI CTEP Approved Trials For the Month of January

January 31, 2014

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

Drug Development Effort Criticized

April 18, 1975